Gene · 3376
NIH grants1,644
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,644
Download this page as JSON| Grant | Title | IARS1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI125581 | Automated Forward Genetic Analysis of Adaptive Immunity | 1 | 2025 |
| R01AI132374 | Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease | 1 | 2025 |
| R01AI151290 | Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation | 1 | 2025 |
| R01AI153216 | RNA binding and packaging by retroviral Gag proteins | 1 | 2025 |
| R01AR043369 | MITF from control of pigmentation to melanoma risk | 1 | 2025 |
| R01AR046713 | Cytokine regulation of RA synoviocyte phenotype | 1 | 2025 |
| R01AR050401 | Cytokine Balance in Rheumatoid Arthritis | 1 | 2025 |
| R01AR080346 | Knee Arthroplasty Activity Trial (KArAT) | 1 | 2025 |
| R01CA046595 | Mitogenic and Oncogenic Regulation of ERK/RSK Signaling | 1 | 2025 |
| R01CA072038 | Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis | 1 | 2025 |
| R01CA090764 | PI3K/PTEN/Akt signaling and the genesis of cancer | 1 | 2025 |
| R01CA118953 | Improving Outcomes Assessment in Chronic Graft versus Host Disease | 1 | 2025 |
| R01CA173852 | Role of p21 activated kinase in Leukemogenesis | 1 | 2025 |
| R01CA184984 | Maximizing the predictive power of high-throughput, microscopy-based phenotypic screens | 1 | 2025 |
| R01CA200709 | Facilitated recruitment of MYC to chromatin by interaction with WDR5 | 1 | 2025 |
| R01CA200900 | Systemic RNA Delivery to Tumors | 1 | 2025 |
| R01CA256791 | Role of Erbb3 kinase activity in colorectal tumorigenesis. | 1 | 2025 |
| R01CA260629 | Role of PTPRT in colon cancer progression and metastasis | 1 | 2025 |
| R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 1 | 2025 |
| R01CA260872 | A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3376/grants?page=8